GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.

TitleGNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.
Publication TypeJournal Article
Year of Publication2016
AuthorsLim, YH, Bacchiocchi, A, Qiu, J, Straub, R, Bruckner, A, Bercovitch, L, Narayan, D, McNiff, J, Ko, C, Robinson-Bostom, L, Antaya, R, Halaban, R, Choate, KA
Corporate AuthorsYale Center for Mendelian Genomics
JournalAm J Hum Genet
Date Published2016 Aug 04

Vascular tumors are among the most common neoplasms in infants and children; 5%-10% of newborns present with or develop lesions within the first 3 months of life. Most are benign infantile hemangiomas that typically regress by 5 years of age; other vascular tumors include congenital tufted angiomas (TAs), kaposiform hemangioendotheliomas (KHEs), and childhood lobular capillary hemangiomas (LCHs). Some of these lesions can become locally invasive and unresponsive to pharmacologic intervention, leading to significant complications. Recent investigation has revealed that activating mutations in HRAS, KRAS, NRAS, GNAQ, and GNA11 can cause certain types of rare childhood vascular tumors, and we have now identified causal recurrent somatic activating mutations in GNA14 by whole-exome and targeted sequencing. We found somatic activating GNA14 c.614A>T (p.Gln205Leu) mutations in one KHE, one TA, and one LCH and a GNA11 c.547C>T (p.Arg183Cys) mutation in two LCH lesions. We examined mutation pathobiology via expression of mutant GNA14 or GNA11 in primary human endothelial cells and melanocytes. GNA14 and GNA11 mutations induced changes in cellular morphology and rendered cells growth-factor independent by upregulating the MAPK pathway. Our findings identify GNA14 mutations as a cause of childhood vascular tumors, offer insight into mechanisms of oncogenic transformation by mutations affecting Gaq family members, and identify potential targets for therapeutic intervention.

Alternate JournalAm. J. Hum. Genet.
PubMed ID27476652
PubMed Central IDPMC4974082
Grant ListP50 CA121974 / CA / NCI NIH HHS / United States
T32 GM007205 / GM / NIGMS NIH HHS / United States
U54 HG006504 / HG / NHGRI NIH HHS / United States
UL1 TR001863 / TR / NCATS NIH HHS / United States